These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28542054)

  • 21. Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
    Dewachter P; Mouton-Faivre C
    Anesthesiology; 2015 Sep; 123(3):735-6. PubMed ID: 26284871
    [No Abstract]   [Full Text] [Related]  

  • 22. Rocuronium is associated with an increased risk of reintubation in patients with soft tissue infections.
    Greco KM; Conti BM; Bucci CJ; Galvagno SM
    J Clin Anesth; 2016 Nov; 34():186-91. PubMed ID: 27687370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same.
    Mertes PM; Volcheck GW
    Anesthesiology; 2015 Jan; 122(1):5-7. PubMed ID: 25383569
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaphylactic reaction to rocuronium bromide.
    Yee R; Fernandez JA
    Anaesth Intensive Care; 1996 Oct; 24(5):601-4. PubMed ID: 8909675
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring.
    Fabregat López J; Porta Vila G; Martin-Flores M
    Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 27. Repeated sugammadex usage in a patient with multiple sclerosis: a case report.
    Sinikoglu N; Totoz T; Gumus F; Karagulle O
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):71-3. PubMed ID: 25586446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaphylactic shock to neuromuscular blocking agent: a familial history.
    Duvaldestin P; Wigdorowicz C; Gabriel I
    Anesthesiology; 1999 Apr; 90(4):1211-2. PubMed ID: 10201697
    [No Abstract]   [Full Text] [Related]  

  • 32. No tolerance to rocuronium-induced neuromuscular blockade in a patient with prolonged testosterone therapy.
    Mizogami M; Mukozawa M; Kohno T; Takakura K
    J Clin Anesth; 2010 Nov; 22(7):579-80. PubMed ID: 21056825
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of depth of neuromuscular blockade on the abdominal space during pneumoperitoneum establishment in laparoscopic surgery.
    Barrio J; Errando CL; San Miguel G; Salas BI; Raga J; Carrión JL; García-Ramón J; Gallego J
    J Clin Anesth; 2016 Nov; 34():197-203. PubMed ID: 27687373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
    Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
    J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin.
    Hasfurther DL; Bailey PL
    Can J Anaesth; 1996 Jun; 43(6):617-20. PubMed ID: 8773869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report.
    Ortiz-Gómez JR; Palacio-Abizanda FJ; Fornet-Ruiz I
    Eur J Anaesthesiol; 2014 Dec; 31(12):708-9. PubMed ID: 24718022
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study.
    Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F
    Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex.
    Unterbuchner C; Ziegleder R; Graf B; Metterlein T
    Acta Anaesthesiol Scand; 2015 Apr; 59(4):536-40. PubMed ID: 25582520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.